| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 医药商业(元) | 409,743,638.84 | 844,582,796.29 | 439,288,623.80 | 909,935,149.77 | 440,846,211.34 |
| 医药制造(元) | 551,106,207.88 | 1,204,225,654.34 | 671,077,411.65 | 1,431,010,368.23 | 764,828,845.34 |
| 营业成本(元) | |||||
| 医药商业(元) | 365,475,382.80 | 756,205,173.56 | 396,988,141.48 | 827,318,204.78 | 400,894,844.24 |
| 医药制造(元) | 145,299,577.01 | 318,861,539.39 | 187,216,163.82 | 344,744,110.73 | 167,610,190.16 |
| 毛利(元) | |||||
| 医药商业(元) | 44,268,256.04 | 88,377,622.73 | 42,300,482.32 | 82,616,944.99 | 39,951,367.10 |
| 医药制造(元) | 405,806,630.87 | 885,364,114.95 | 483,861,247.83 | 1,086,266,257.50 | 597,218,655.18 |
| 毛利率(%) | |||||
| 医药商业(%) | 10.80 | 10.46 | 9.63 | 9.08 | 9.06 |
| 医药制造(%) | 73.63 | 73.52 | 72.10 | 75.91 | 78.09 |
| 收入构成(%) | |||||
| 医药商业(%) | 42.64 | 41.22 | 39.56 | 38.87 | 36.56 |
| 医药制造(%) | 57.36 | 58.78 | 60.44 | 61.13 | 63.44 |
| 毛利构成(%) | |||||
| 医药商业(%) | 9.84 | 9.08 | 8.04 | 7.07 | 6.27 |
| 医药制造(%) | 90.16 | 90.92 | 91.96 | 92.93 | 93.73 |